mirtazapine tablet, film coated
preferred pharmaceuticals, inc. - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine 15 mg - mirtazapine tablets are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine tablets in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation. the effectiveness of mirtazapine tablets in
mirtazapine tablet, film coated
preferred pharmaceuticals inc. - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine tablets are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine tablets in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation. the effectiveness of mirtazapine tablets in
health smart medicated body- menthol and zinc oxide powder
international wholesale inc dba home smart products - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - purpose external analgesic skin protectant uses for the temporary relief of pains and itch associated with: - minor cuts - scrapes - sunburn - insect bites - prickly heat - rashes - minor burns - minor skin irritation - dries the oozing of poison ivy, oak, and sumac.
victor fast-heal 0.002 spray solution
international pharmaceuticals, inc. - benzalkonium chloride (vet.) - spray solution - 0.002
victor wound cleanser 0.03 spray solution (10 volumes)
international pharmaceuticals, inc. - hydrogen peroxide (vet.) - spray solution (10 volumes) - 0.03
none 0.2 ml per 100 ml solution
international pharmaceuticals, inc. - aceite de manzanilla - solution - 0.2 ml per 100 ml
none 10g per 100ml solution
international pharmaceuticals, inc - camphor (aceite de alcamforado) - solution - 10g per 100ml
broncho rub-citrus 7.2 g/4 g/4 g per 100 g ointment
international pharmaceuticals, inc. - camphor , menthol , eucalyptus oil - ointment - 7.2 g/4 g/4 g per 100 g
broncho rub-citrus 7.2 g / 4 g / 4 g per 100 g ointment
international pharmaceuticals, inc. - camphor , menthol , eucalyptus oil - ointment - 7.2 g / 4 g / 4 g per 100 g
broncho rub 7.2 g/4 g/4 g per 100 g ointment
international pharmaceuticals, inc. - camphor , menthol , eucalyptus oil - ointment - 7.2 g/4 g/4 g per 100 g